UnknownNot Applicable

Relevance of Ultrasound Screening for Foetal Macrosomia

France3,000 participantsStarted 2020-06

Plain-language summary

Management of fetal macrosomia is based on a suspicion of macrosomia (no certainty before birth). This management is an artificial induction of labour for an earlier delivery and therefore a lower fetal weight gain. Several studies have already shown that ultrasound performed during the third trimester of pregnancy was not a perfect tool for this screening.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria : Patients (consecutive inclusions) : Women pregnant Women followed in the gynaecology and obstetrics department of the CHU of Reims, the CHG of Charleville Mézières or the CHG of Chalons en Champagne. Women for which the delivery is planned in the gynaecology and obstetrics department of the Reims University Hospital, the Charleville Mézières General Hospital or the Chalons en Champagne General Hospital. Non-inclusion criteria Women without ultrasound dating scan in the first trimester. Women having a contraindication to labour or vaginal delivery Women with a scarred uterus Women having a history of shoulder dystocia or obstetric trauma Women having a history of urinary or fecal incontinence Women having a history of bad birth experience with high psychological impact Women with maternal pathologies (excluding gestational diabetes) Women whose fetus is breech Women with twin pregnancy

What they're measuring

Foetal macrosomia

Timeframe: Baseline

Trial details

NCT IDNCT04443205

SponsorCHU de Reims

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-09

Contact for this trial

Uzma ISHAQUE

03 10 73 62 88 uishaque@chu-reims.fr

View on ClinicalTrials.gov More Pregnancy trials